Seven acquisitions and more than 80 in-licensing transactions closed during 2020 helped privately-held Stada to last year increase revenues, adjusted for currency effects, by 18% to €3.01bn ($3.59bn), “well ahead of a stagnating market,” as the German company’s adjusted earnings before interest and tax rose by 16% to €595m.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?